ALAB - Astera Labs Inc
121
$126.16
-$0.18 (-0.142%)
At market close
$126.02
-$0.14 (-0.110%)
Pre Market 3/20/26, 8:33 AM
Score3.89/5
Price Targets
These are one year price targets for: 2027-02-21
High:
$262.50
108.1%
Avg:
$206.23
63.5%
Low:
$156.55
24.1%
% change is relative to the current stock price ($126.16).
Most Recent Recommendations
4.04
Good
25%
Strong Buy (7)
54%
Buy (15)
21%
Hold (6)
0%
Sell (0)
0%
Strong Sell (0)
Revenue Estimate
- Past Revenue
- Avg
- High
- Low
EPS Estimate
- Past EPS
- Avg
- High
- Low
Revenue Estimate as % change
YoY is the % change of each analyst estimate, relative to the prior year
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Low | 48.8% | 24.4% | 24.5% | 4.70% | 8.22% |
| Avg | 61.4% | 37.6% | 27.8% | 7.85% | -15.0% |
| High | 81.3% | 56.4% | 25.2% | 4.37% | -30.0% |
EPS Estimate as % change
YoY is the % change of each analyst estimate, relative to the prior year
| 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|
| Low | 27.8% | 31.1% | 20.7% | 68.5% |
| Avg | 37.0% | 41.5% | 29.9% | 34.1% |
| High | 60.6% | 62.8% | 13.8% | 12.8% |
Recommendation Trends
- Strong Sells
- Sells
- Holds
- Buys
- Strong Buys
Latest Analyst Ratings
Institution | Action | Grade | Old Grade | Date |
|---|---|---|---|---|
| Loop Capital | Init | Buy | -- | 2026-03-05 |
| Citigroup | Maintain | Buy | Buy | 2026-02-11 |
| RBC Capital | Init | Outperform | -- | 2026-01-15 |
| Northland Capital Markets | Maintain | Outperform | Outperform | 2025-12-09 |
| BNP Paribas Exane | Init | Outperform | -- | 2025-11-20 |
| Northland Capital Markets | Upgrade | Outperform | Market Perform | 2025-11-17 |
| Roth Capital | Maintain | Buy | Buy | 2025-11-05 |
| Morgan Stanley | Maintain | Overweight | Overweight | 2025-11-05 |
| TD Cowen | Maintain | Hold | Hold | 2025-11-05 |
| JP Morgan | Maintain | Overweight | Overweight | 2025-11-05 |